CIK 0001425205 · Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753254381
- Phone
- 6502607120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-03 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Shares withheld for taxes | −1,983 | $10.85 | $22K | 47,795 |
| 2024-09-03 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise | +23,438 | 71,233 | ||
| 2024-09-03 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Shares withheld for taxes | −11,891 | $10.85 | $129K | 59,342 |
| 2024-09-03 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise · Restricted Stock Units | −3,907 | 23,439 | ||
| 2024-09-03 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise · Restricted Stock Units | −23,438 | 23,437 | ||
| 2024-09-03 | BILINSKY IGOR Chief Operating Officer | Option exercise | +3,516 | 44,659 | ||
| 2024-09-03 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −1,784 | $10.85 | $19K | 42,875 |
| 2024-09-03 | BILINSKY IGOR Chief Operating Officer | Option exercise | +23,438 | 66,313 | ||
| 2024-09-03 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −11,891 | $10.85 | $129K | 54,422 |
| 2024-09-03 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −3,516 | 21,097 | ||
| 2024-09-03 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −23,438 | 23,437 | ||
| 2024-09-03 | Bellemin Jean-Marc Chief Financial Officer | Option exercise | +23,438 | 41,239 | ||
| 2024-09-03 | Bellemin Jean-Marc Chief Financial Officer | Shares withheld for taxes | −11,891 | $10.85 | $129K | 29,348 |
| 2024-09-03 | Bellemin Jean-Marc Chief Financial Officer | Option exercise · Restricted Stock Units | −23,438 | 23,437 | ||
| 2024-07-15 | Vogt Frederick G Interim CEO & General Counsel | Option exercise | +20,835 | 168,160 | ||
| 2024-07-15 | Vogt Frederick G Interim CEO & General Counsel | Shares withheld for taxes | −8,851 | $8.68 | $77K | 159,309 |
| 2024-07-15 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −20,835 | 41,669 | ||
| 2024-07-15 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise | +2,813 | 47,299 | ||
| 2024-07-15 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Shares withheld for taxes | −1,428 | $8.68 | $12K | 45,871 |
| 2024-07-15 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise · Restricted Stock Units | −2,813 | 5,626 |
Page 13 of 14 · 280 trades